The primary goal of this preclinical translational proposal is to determine the role of erythroblast macrophage protein (Emp) in tumor progression and to establish its prognostic and predictive value for colorectal cancers (CRCs). In our published and preliminary studies, we have discovered that Emp is involved in erythroblast enucleation, macrophage development, cell growth and differentiation, and cell adhesion and migration. These pathways are hallmarks of cancer progression. Additionally, our preliminary immunohistochemical (IHC) evaluations of human CRC tissues have demonstrated increasing expression of Emp in progression of adenomas to primary adenocarcinomas to metastatic carcinomas. Therefore, we hypothesize that Emp is involved in CRC progression. To test this hypothesis, we propose to evaluate the role of Emp interactions with adhesion molecules for attachment to extracellular membranes (ECM), for molecular cross-talk, for effects on the tumor microenvironment, and for progression of CRCs. This will be accomplished in three aims.
Aim -1 will determine the interaction of Emp with ?1 integrin within focal adhesion plaques and its involvement in tumor progression;
Aim -2 will verify the interaction of Emp with the actin cytoskeleton in ECM functions and in metastasis;
and Aim -3 will establish the prognostic and predictive value of Emp in CRCs. The proposed studies will characterize the molecular interactions of Emp with ?1 integrin, ascertain the effects of Emp on the actin cytoskeleton and other components of the ECM, identify new molecular determinants that contribute to tumor progression, and assess the predictive and prognostic value of Emp in CRCs.
SUMMARY An increased expression of erythroblast macrophage protein (Emp) was identified in preliminary studies of premalignant and malignant lesions of the colorectum. Moreover, abnormal Emp was significantly associated with cell proliferation, growth, differentiation, invasion, adhesion and migration. Therefore, this study will validate the prognostic (disease recurrence and survival) and predictive (efficacy of therapy) value of Emp in colorectal cancers (CRCs). It will also identify sets of Emp-dependent molecular targets that are associated with aggressive behavior of CRCs. These results will provide information that will guide further studies of biologic mechanisms in understanding the role of Emp in CRC tumor progression and in conducting preclinical and clinical studies to assess its usefulness in determining the clinical outcomes.
|Kumar, Sanjay; Stokes 3rd, James; Singh, Udai P et al. (2016) Targeting Hsp70: A possible therapy for cancer. Cancer Lett 374:156-66|
|Kvale, Elizabeth; Dionne-Odom, J Nicholas; Redden, David T et al. (2015) Predictors of Physical Restraint Use in Hospitalized Veterans at End of Life: An Analysis of Data from the BEACON Trial. J Palliat Med 18:520-6|
|Karthikeyan, Chandrabose; Lee, Crystal; Moore, Joshua et al. (2015) IND-2, a pyrimido[1â€³,2â€³:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells. Bioorg Med Chem 23:602-11|
|Bakitas, Marie A; Tosteson, Tor D; Li, Zhigang et al. (2015) Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial. J Clin Oncol 33:1438-45|
|Wang, Lizhong; Liu, Runhua; Ye, Peiying et al. (2015) Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nat Commun 6:5909|
|Higgs, Jerome T; Jarboe, John S; Lee, Joo Hyoung et al. (2015) Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. Mol Cancer Res 13:819-27|
|Dionne-Odom, J Nicholas; Willis, Danny G; Bakitas, Marie et al. (2015) Conceptualizing surrogate decision making at end of life in the intensive care unit using cognitive task analysis. Nurs Outlook 63:331-40|
|Dionne-Odom, J Nicholas; Azuero, Andres; Lyons, Kathleen D et al. (2015) Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial. J Clin Oncol 33:1446-52|
|Tabatabai, M A; Li, H; Eby, W M et al. (2014) Robust Logistic and Probit Methods for Binary and Multinomial Regression. J Biom Biostat 5:|
|Khazal, Kamel F; Hill, Donald L; Grubbs, Clinton J (2014) Effect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice. Anticancer Res 34:6327-32|
Showing the most recent 10 out of 33 publications